Yossan‐Var Tan

发表

Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis

A. Campagnoni, J. Waschek, Hongmei Dong, 2010, Proceedings of the National Academy of Sciences.

Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis

J. Waschek, Hongmei Dong, J. Leceta, 2009, Proceedings of the National Academy of Sciences.

Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist

C. Colwell, M. Fanselow, Michael C. Condro, 2015, Psychopharmacology.

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

J. Waschek, M. O'dorisio, C. Abad, 2016, Journal of Neuroinflammation.

Calcium Signaling via Orai1 Is Essential for Induction of the Nuclear Orphan Receptor Pathway To Drive Th17 Differentiation

R. Damoiseaux, Y. Gwack, S. Srikanth, 2014, The Journal of Immunology.

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

J. Waschek, M. O'dorisio, C. Abad, 2017, Journal of Neuroinflammation.

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses

J. Waschek, Yuqi Wang, C. Abad, 2015, Brain, Behavior, and Immunity.

VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses

J. Waschek, C. Abad, Yossan-Var Tan, 2012, PloS one.

The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.

A. Couvineau, S. Murail, E. Ceraudo, 2008, Molecular endocrinology.

VIP and PACAP as Regulators of Immunity: New Perspectives from A Receptor Point of View

C. Abad, Yossan‐Var Tan, 2016 .

Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice

C. Abad, Yossan-Var Tan, Yossan‐Var Tan, 2018, Journal of Molecular Neuroscience.

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis

J. Waschek, Yossan‐Var Tan, 2011, ASN neuro.

Strategies for studying the ligand binding site of GPCRs: photoaffinity labeling of the VPAC1 receptor, a prototype of class B GPCRs.

A. Couvineau, E. Ceraudo, M. Laburthe, 2013, Methods in enzymology.

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

G. Riou, A. Couvineau, O. Boyer, 2019, Journal of Neuroinflammation.

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases

T. Voisin, A. Couvineau, P. Nicole, 2019, Front. Endocrinol..

Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs

A. Nicke, N. Schwarz, F. Koch-Nolte, 2022, Frontiers in Pharmacology.

Photoaffinity Labeling Demonstrates Physical Contact between Vasoactive Intestinal Peptide and the N-terminal Ectodomain of the Human VPAC1 Receptor*

A. Couvineau, M. Laburthe, Yossan-Var Tan, 2003, Journal of Biological Chemistry.

Peptide Agonist Docking in the N-terminal Ectodomain of a Class II G Protein-coupled Receptor, the VPAC1 Receptor

A. Couvineau, S. Murail, E. Ceraudo, 2006, Journal of Biological Chemistry.

Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE

J. Waschek, Yuqi Wang, C. Abad, 2013, PloS one.

VPAC1 receptor binding site: Contribution of photoaffinity labeling approach

A. Couvineau, E. Ceraudo, M. Laburthe, 2010, Neuropeptides.

Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction

A. Couvineau, S. Murail, P. Robberecht, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

J. Waschek, Yuqi Wang, M. O'dorisio, 2017, Journal of Neuroinflammation.

Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice

C. Abad, Yossan‐Var Tan, 2018, Journal of Molecular Neuroscience.

The Human VPAC1 Receptor

A. Couvineau, S. Murail, M. Laburthe, 2006, Annals of the New York Academy of Sciences.

This information is current as Pathway To Drive Th 17 Differentiation Induction of the Nuclear Orphan Receptor Calcium Signaling via Orai 1 Is Essential for Waschek and Yousang Gwack

R. Damoiseaux, Y. Gwack, J. Waschek, 2013 .

This information is current as Pathway To Drive Th 17 Differentiation Induction of the Nuclear Orphan Receptor Calcium Signaling via Orai 1 Is Essential for Waschek and Yousang Gwack Saki

R. Damoiseaux, Y. Gwack, J. Waschek, 2013 .

This information is current as Pathway To Drive Th 17 Differentiation Induction of the Nuclear Orphan Receptor Calcium Signaling via Orai 1 Is Essential for Waschek and Yousang Gwack

R. Damoiseaux, J. Waschek, B. Ribalet, 2013 .

Identification of Cytoplasmic Domains of hVPAC1 Receptor Required for Activation of Adenylyl Cyclase

A. Couvineau, M. Laburthe, P. Nicole, 2003, Journal of Biological Chemistry.

Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice

S. Adriouch, H. Gondé, Mélanie Demeules, 2024, Journal of nanobiotechnology.

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses

J. Waschek, Yuqi Wang, C. Abad, 2015, Brain, Behavior, and Immunity.

Diffuse Pharmacophoric Domains of Vasoactive Intestinal Peptide (VIP) and Further Insights into the Interaction of VIP with the N-terminal Ectodomain of Human VPAC1 Receptor by Photoaffinity Labeling with [Bpa6]-VIP*

A. Couvineau, M. Laburthe, Yossan-Var Tan, 2004, Journal of Biological Chemistry.